Stock INAB IN8BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart IN8bio, Inc.

Equities

INAB

US45674E1091

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-20 EDT 		5-day change 1st Jan Change
1.02 USD -0.97% Intraday chart for IN8bio, Inc. 0.00% -26.09%
05-13 HC Wainwright Adjusts Price Target on IN8bio to $12.50 From $14, Keeps Buy Rating MT
05-13 In8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Presentation At Asgct 2024 CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
IN8BIO, INC.
Bio Therapeutic Drugs
-0.97%0.00%-26.09%-62.50% - 45.34M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. INAB Stock
  4. Charts IN8bio, Inc.
  5. Relative Strength Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW